{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-018629","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2023-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.624081+00:00","generated_at":"2026-06-13T15:56:53.916598+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BIO-key amends securities purchase agreement, waives defaults with AJB Capital","bullets":["Amends Dec 2022 agreement: repurchase of up to 272k commitment shares if principal paid by July 22, 2023; up to 214k if paid by Aug 21, 2023, each for $1.00.","Waives events of default related to late filing of Q1 2023 Form 10-Q and failure to timely register shares; registration waiver expires July 30, 2023.","Original $2.2M note and 700k commitment shares issued in December 2022; amendment adjusts repurchase rights based on principal payment timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-018629","json":"https://secwatch.observer/filing/0001437749-23-018629.json","markdown":"https://secwatch.observer/filing/0001437749-23-018629.md","text":"https://secwatch.observer/filing/0001437749-23-018629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/0001437749-23-018629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/bkyi20230626_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:56:53.916598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ae71ba446d4d72e1919df46dda6bf205856f24d","claim":"BIO KEY INTERNATIONAL INC amended Waiver and Amendment No. 1 to Securities Purchase Agreement with AJB Capital Investments, LLC (effective 2023-06-22).","evidence_excerpt":"On June 22, 2023, BIO-key International, Inc. (the “Company,” “we” or “us”) entered into a Waiver and Amendment No. 1 to Securities Purchase Agreement (the “Amendment”) with AJB Capital Investments, LLC (the “Investor”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/0001437749-23-018629-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"AJB Capital Investments, LLC"},{"label":"Effective","value":"2023-06-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}